Pfizer plans to submit for full approval of Covid vaccine in late May
Pfizer plans to file for full U.S. approval of its Covid-19 vaccine with German drugmaker BioNTech at the end of this month. If the FDA signs off, the company will be able to market the shot directly to consumers. CNBC's Meg Tirrell reports.
Tue, May 4 20218:19 AM EDT